Works matching IS 02683369 AND DT 2000 AND VI 25 AND IP 11

Results: 17

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1141, doi. 10.1038/sj.bmt.1702426

By:

Vela-Ojeda, J;
Tripp-Villanueva, F;
Montiel-Cervantes, L;
Sánchez-Cortés, E;
Ayala-Sánchez, M;
Guevara-Moreno, M E;
García-León, L D;
Rosas-Cabral, A;
Esparza, MA García-Ruiz;
González-Llaven, J

Publication type:

Article

A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1129, doi. 10.1038/sj.bmt.1702422

By:

Heldal, D;
Tjønnfjord, G;
Brinch, L;
Albrechtsen, D;
Egeland, T;
Steen, R;
Solheim, B G;
Evensen, S A

Publication type:

Article

Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1147, doi. 10.1038/sj.bmt.1702420

By:

Janssen, J J W M;
van Rijn, R S;
van der Holt, B;
Schuurhuis, G-J;
Vellenga, E;
Verhoef, G E G;
Ossenkoppele, G J;
van den Berg, E;
Hagemeijer, A;
Släter, R;
Nieuwint, A W M;
Cornelissen, J J

Publication type:

Article

Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1115, doi. 10.1038/sj.bmt.1702389

By:

Reiffers, J;
Labopin, M;
Sanz, M;
Korbling, M;
Blaise, D;
De La Rubia, J;
Gorin, N C

Publication type:

Article

Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1185, doi. 10.1038/sj.bmt.1702391

By:

Chatterjee, R;
Andrews, H O;
McGarrigle, H H;
Kottaridis, P D;
Lees, W R;
Mackinnon, S;
Ralph, D J;
Goldstone, A H

Publication type:

Article

Cunninghamella infection post bone marrow transplant: case report and review of the literature.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1213, doi. 10.1038/sj.bmt.1702395

By:

Darrisaw, L;
Hanson, G;
Vesole, D H;
Kehl, S C

Publication type:

Article

Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1157, doi. 10.1038/sj.bmt.1702406

By:

Yu, J;
Leisenring, W;
Fritschle, W;
Heimfeld, S;
Shulman, H;
Bensinger, W I;
Holmberg, L A;
Rowley, S D

Publication type:

Article

CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1175, doi. 10.1038/sj.bmt.1702408

By:

Dyson, P G;
Horvath, N;
Joshua, D;
Barrow, L;
Van Holst, N G;
Brown, R;
Gibson, J;
To, L B

Publication type:

Article

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1121

By:

Simonsson, B;
Tötterman, T;
Hokland, P;
Lauria, F;
Carella, A M;
Fernandez, M N;
Rozman, C;
Ferrant, A;
de Witte, T;
Zander, A R;
Meier, K;
Hansson, F;
Nilsson, B I

Publication type:

Article

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1165, doi. 10.1038/sj.bmt.1702415

By:

Yanovich, S;
Mitsky, P;
Cornetta, K;
Maziarz, R T;
Rosenfeld, C;
Krause, D S;
Lotz, J-P;
Bitran, J D;
Williams, S;
Preti, R;
Somlo, G;
Burtness, B;
Mills, B

Publication type:

Article

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1203

By:

Martínez-Climent, J A;
Comes, A M;
Vizcarra, E;
Benet, I;
Arbona, C;
Prósper, F;
Solano, C;
Clavel, B García;
Marugán, I;
Lluch, A;
García-Conde, J

Publication type:

Article

A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1209, doi. 10.1038/sj.bmt.1702418

By:

Saito, Y;
Uzuka, Y;
Sakai, N;
Suzuki, S;
Toyota, T

Publication type:

Article

Validation of self-reported complications by bone marrow transplantation survivors.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1191, doi. 10.1038/sj.bmt.1702419

By:

Louie, A D;
Robison, L L;
Bogue, M;
Hyde, S;
Forman, S J;
Bhatia, S

Publication type:

Article

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1197, doi. 10.1038/sj.bmt.1702423

By:

Khoury, H;
Adkins, D;
Brown, R;
Vij, R;
Westervelt, P;
Trinkaus, K;
Goodnough, L T;
DiPersio, J F

Publication type:

Article

High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1137, doi. 10.1038/sj.bmt.1702421

By:

Donato, M. L.;
Gershenson, D.;
Ippoliti, C.;
Wharton, J. T.;
Bast, R. C.;
Aleman, A.;
Anderlini, P.;
Gajewski, J. G.;
Giralt, S.;
Molldrem, J.;
Ueno, N.;
Lauppe, J.;
Korbling, M.;
Boyer, J.;
Bodurka-Bevers, D.;
Bevers, M.;
Burke, T.;
Freedman, R.;
Levenback, C.;
Wolf, J.

Publication type:

Article

Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombotic thrombocytopenic purpura.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1217, doi. 10.1038/sj.bmt.1702441

By:

Alessandrino, E P;
Martinelli, G;
Canevari, A;
Bernasconi, P;
Caldera, D;
Colombo, A;
Bernasconi, C

Publication type:

Article

Response.

Published in:

Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1218, doi. 10.1038/sj.bmt.1702442

By:

Milone, J;
Napal, J;
Etchegoyen, O;
Morales, V

Publication type:

Article

Works matching IS 02683369 AND DT 2000 AND VI 25 AND IP 11

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.

A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.

Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.

Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.

Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies.

Cunninghamella infection post bone marrow transplant: case report and review of the literature.

Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34<sup>+</sup> cell yield in the apheresis collection.

CD34<sup>+</sup> selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma.

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.

Transplantation of CD34<sup>+</sup> peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.

Validation of self-reported complications by bone marrow transplantation survivors.

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.

High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.

Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombotic thrombocytopenic purpura.

Response.